CID 168010351

Varlaxin 754

Structural Information

Molecular Formula
C30H54N6O14S
SMILES
CCC(C)C(C(=O)N1C2CC(CCC2CC1C(=O)NCCCCN=C(N)N)OC3C(C(C(C(O3)CO)O)O)O)NC(=O)C(COS(=O)(=O)O)OC
InChI
InChI=1S/C30H54N6O14S/c1-4-15(2)22(35-27(42)21(47-3)14-48-51(44,45)46)28(43)36-18-12-17(49-29-25(40)24(39)23(38)20(13-37)50-29)8-7-16(18)11-19(36)26(41)33-9-5-6-10-34-30(31)32/h15-25,29,37-40H,4-14H2,1-3H3,(H,33,41)(H,35,42)(H4,31,32,34)(H,44,45,46)
InChIKey
RAJLZDCTCSZRRK-UHFFFAOYSA-N
Compound name
[3-[[1-[2-[4-(diaminomethylideneamino)butylcarbamoyl]-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-2-methoxy-3-oxopropyl] hydrogen sulfate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

754.34186 Da
Monoisotopic Mass

-2.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 755.34914 258.6
[M+Na]+ 777.33108 256.9
[M-H]- 753.33458 256.7
[M+NH4]+ 772.37568 259.1
[M+K]+ 793.30502 258.3
[M+H-H2O]+ 737.33912 242.8
[M+HCOO]- 799.34006 260.1
[M+CH3COO]- 813.35571 263.3
[M+Na-2H]- 775.31653 285.7
[M]+ 754.34131 276.6
[M]- 754.34241 276.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.